The Precision Health Initiative is conducted by Genuity Science. Listen to our new podcast here.

Genuity Science Opens New U.S. Corporate Headquarters in Downtown Boston, Continuing its Commitment to the Bay State’s Healthcare and Genomics Innovation Hub

Genuity Science, a genomics and data insights organization, announced today its U.S. corporate headquarters have moved from Cambridge, Mass. to their  new location at 90 Canal Street in Downtown Boston’s historic North Station area. Genuity remains committed to being present in the Bay State, where a number of big data and genomics companies also call home.

The move to the new 7,700-square foot office space supports the company’s multi-year strategic growth initiatives, enabling Genuity to continue to capitalize on the unique and innovative genomics and biopharma talent pool in Boston as it continues to expand its leadership, sales, engineering, and marketing teams.

“The convergence of many industries in the Boston area—life sciences, biopharma, and genomics—makes the area the most unique and innovative of healthcare hubs,” said Chief Executive Officer Rob Brainin. “We are in the best location to make our mark as the leading purveyor of deep genomic data and novel biological insights that global companies require to accelerate and refine the process of drug discovery. We look forward to the long-term opportunities Boston affords us—not only for our colleagues in the U.S., but also in Ireland, Iceland, and around the world.”

About the Facility
Located in Boston’s historic West End, 90 Canal Street is a 6-story, 77,979-square foot building constructed in 1906 and renovated in 1987. Located near North Station and one block from MBTA station (Haymarket), Genuity’s offices were designed by SMMA, a well-regarded design firm located in Cambridge, Mass.